Scott Bradley

VP Product Development Consulate General of Canada (CTA Boston)

Cambridge MA

Scott Bradley is a digital and eClinical technology expert, business leader and entrepreneur.

Contact

Consulate General of Canada (CTA Boston)
View more experts managed by Consulate General of Canada (CTA Boston)

View all Experts

Social

Biography

Scott is a digital health and eClinical technology expert, business leader and entrepreneur, with experience at market-leading companies such as Boston Scientific, IQVIA and ERT as well as new start-ups such as CentrosHealth and OM1. He's worked extensively with medical devices and sensor integration, patient engagement and UX, and clinical outcomes assessment. He is now leading a new business and technology platform at CENDUIT, and his volunteer activities include serving as a board member for the New England Chapter of HIMSS.

Industry Expertise

Health Care - Services

Electrical Engineering

Corporate Leadership

Areas of Expertise

Patient Engagement

Technology

Medical Devices

Education

University of Minnesota - Carlson School of Management

M.B.A.

Marketing

2007

Saint Martin's University

M.E.M.

Engineering Management

2001

United States Military Academy at West Point

B.S.

Electrical Engineering

1998

Affiliations

HIMSS : New England Chapter, Board of Directors
Canadian Technology Accelerator : Mentor

Selected Articles

Feasibility of the “Bring Your Own Device” Model in Clinical Research: Results from a Randomized Controlled Pilot Study of a Mobile Patient Engagement Tool

Cureus

Laura Pugliese, Molly Woodriff, Olga Crowley, Vivian Lam, Jeremy Sohn, Scott Bradley

2016

Rising rates of smartphone ownership highlight opportunities for improved mobile application usage in clinical trials. While current methods call for device provisioning, the "bring your own device” (BYOD) model permits participants to use personal phones allowing for improved patient engagement and lowered operational costs. However, more evidence is needed to demonstrate the BYOD model’s feasibility in research settings.